If the viewer doesn’t load, use the
direct PDF link.

Introduction: Expanding the Role of Lasers in Body Contouring

The demand for non-invasive fat reduction has skyrocketed as patients increasingly seek alternatives to liposuction that require little to no downtime. One of the most exciting technologies in this space is the 1060 nm diode laser, designed to selectively target subcutaneous fat cells through controlled hyperthermia. Unlike surgical procedures, this approach requires no anesthesia, no incisions, and has a short recovery period—making it appealing to a wide demographic of patients.

But how safe and effective is this treatment in practice? That’s the question this 2023 peer-reviewed study set out to answer. Co-authored by John Hoopman, CMLSO, the paper analyzed outcomes of flank fat reduction using a single 1060 nm diode laser treatment. The results not only demonstrate the technology’s clinical promise but also provide essential data for providers looking to integrate body contouring into their practice. Just as importantly, the study reinforces why Laser Course Aesthetic Training is essential for translating device science into predictable patient outcomes.

Methods: How the Study Was Conducted

Researchers recruited adult patients seeking flank fat reduction. Inclusion criteria required stable weight and good general health. Each patient received a single 25-minute treatment with the 1060 nm diode laser, with applicators positioned over the flank region. Parameters were standardized based on device manufacturer protocols, and patients were monitored for tolerability and adverse events.

Assessments included:

• Safety: Monitoring for pain, erythema, swelling, or adverse tissue reactions.
• Efficacy: Ultrasound measurement of fat thickness before treatment and at 12 weeks post-treatment.
• Patient Satisfaction: Surveys assessing comfort, satisfaction with results, and likelihood of recommending treatment.

By combining objective imaging data with subjective patient-reported outcomes, the study offers a well-rounded evaluation of the treatment’s clinical value.

Results: What the Data Revealed

• Fat Reduction: Ultrasound showed a significant decrease in flank fat thickness at 12 weeks, confirming the laser’s efficacy.
• Safety Profile: No serious adverse events were reported. The most common side effects were mild and transient, such as warmth, erythema, or temporary tenderness.
• Patient Satisfaction: The majority of patients reported being satisfied with their outcomes, noting improved contour and confidence in appearance.
• Treatment Tolerance: Most patients described the treatment as comfortable, with manageable levels of warmth but no need for anesthesia.

Taken together, the results validate the 1060 nm diode laser as a safe, effective, and patient-friendly option for nonsurgical flank reduction. Just as importantly, the outcomes highlight the need for providers to master device positioning, patient selection, and post-treatment care—skills emphasized in Laser Course Aesthetic Training.

Clinical Interpretation: Beyond the Numbers

While the numbers confirm that fat reduction is achievable, the real-world takeaway is that outcomes hinge on provider expertise. Parameters may be standardized, but details like applicator placement, patient hydration, and skin type considerations determine whether the results meet or exceed expectations.

This is where structured training becomes essential. In John Hoopman’s Laser Course Aesthetic Training, providers learn not just the science but also the art of applying it—how to assess candidacy, counsel patients, avoid pitfalls, and deliver repeatable results across diverse patient populations.

Training Implications: What Providers Can Learn

The study underscores several core lessons for providers integrating non-invasive fat reduction into their aesthetic practices:

• Patient Selection is Critical: Ideal candidates are those with localized flank fat resistant to diet and exercise.
• Parameter Discipline: Proper calibration ensures fat destruction without harming surrounding tissue.
• Endpoint Recognition: Monitoring skin response during treatment helps avoid overtreatment or patient discomfort.
• Aftercare Protocols: Clear instructions on hydration, activity, and follow-up optimize results and patient satisfaction.

These lessons are woven directly into John’s Laser Course Aesthetic Training, providing clinicians with a playbook that accelerates confidence and competence.

Safety: Reinforcing Trust in Technology

Safety is often the deciding factor for patients choosing between invasive and non-invasive procedures. This study found no unexpected adverse events, supporting the 1060 nm diode laser’s strong safety profile. Providers who complete Laser Course Aesthetic Training gain structured safety protocols, including:

• Pre-treatment risk assessment checklists
• Contraindication screening (e.g., pregnancy, implanted devices)
• Strategies for managing mild adverse events
• Documentation templates that reduce liability and improve communication

Why Train with John Hoopman

As co-author of this clinical study, John Hoopman doesn’t just teach from textbooks—he teaches from evidence. His Laser Course Aesthetic Training connects peer-reviewed research with real-world protocols, ensuring that providers walk away with more than knowledge: they walk away with systems that protect patients and grow practices.

• Evidence-based: Training rooted in published outcomes like this study.
• Device-agnostic: Principles apply across multiple body contouring platforms, not just one brand.
• Scalable: Designed for individual providers, team practices, and multi-site organizations.
• Practical: Immediate implementation through parameter ladders, checklists, and communication scripts.

Laser Course Aesthetic Training: How to Get Started

Suggested Citation

Makino K, Hoopman J, et al.
Clinical evaluation of the safety and efficacy of a 1060 nm diode laser for non-invasive fat reduction of the flanks.
Journal of Cosmetic Dermatology. 2023.
View on ResearchGate

📄 Download the full study (PDF on JohnHoopman.com)